Association between longer hospitalization and development of de novo donor specific antibodies in simultaneous liver–kidney transplant recipients

BACKGROUND: De novo Donor Specific Antibodies (DSA) are considered as a risk factor for the kidney allograft outcomes in recipients after simultaneous liver–kidney transplantation (SLKT). We hypothesized that length of hospital stay (LOS) might be associated with de novo DSA development of due to th...

Descripción completa

Detalles Bibliográficos
Autores principales: Yazawa, Masahiko, Cseprekal, Orsolya, Helmick, Ryan A., Talwar, Manish, Balaraman, Vasanthi, Podila, Pradeep S. B., Fossey, Sallyanne, Satapathy, Sanjaya K., Eason, James D., Molnar, Miklos Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968335/
https://www.ncbi.nlm.nih.gov/pubmed/31875761
http://dx.doi.org/10.1080/0886022X.2019.1705338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968335/
https://www.ncbi.nlm.nih.gov/pubmed/31875761
http://dx.doi.org/10.1080/0886022X.2019.1705338

Ejemplares similares